Oncogene-induced cellular senescence: Causal factor in the growth arrest of pituitary microadenomas?

Hormone Research

Volumn 71, Issue SUPPL. 2, 2009, Pages 78-81

  Mooi, Wolter J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Microadenoma; Oncogene induced cellular senescence; Pituitary gland; Tumour progression

Indexed keywords

CARCINOGENESIS; CELL AGING; CONFERENCE PAPER; GROWTH INHIBITION; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL AGING; CELL PROLIFERATION; HUMANS; MICE; ONCOGENES; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 66749157936     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000192442     Document Type: Conference Paper

References (23)

1. Levy A: Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin North Am 2008;37:23-50, vii.
2. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-724.
3. Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
4. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
5. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW: Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113: 703-716.
6. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddie SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, the putative human telomerase catalytic sub-unit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-795.
7. Muntoni A, Reddel RR: The first molecular details of ALT in human tumor cells. Hum Mol Genet 2005;14:R191-R196.
8. Shay JW, Wright WE: Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 2000; 1:72-76.
9. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
10. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-198.
11. Franza BR Jr, Maruyama K, Garrels JI, Ruley HE: In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 1986;44:409-418.
12. Land H, Parada LF, Weinberg RA: Tumori-genic conversion of primary embryo fibroblasts requires at least two cooperatingonco-genes. Nature 1983;304:596-602.
13. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88: 593-602.
14. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW: Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mito-genic signaling. Genes Dev 1998; 12:3008-3019.
15. Zhu J, Woods D, McMahon M, Bishop JM: Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998; 12:2997-3007.
16. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA: Onco-gene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-665.
17. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M: Tumour biology: senescence in premalignant tumours. Nature 2005;436: 642.
18. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD, Berghmans S, Mayhall EA, Traver D, Fletcher CD, Aster JC, Granter SR, Look AT, Lee C, Fisher DE, Zon LI: BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005;15:249-254.
19. Minoo P, Jass JR: Senescence and serration: a new twist to an old tale. J Pathol 2006;210: 137-140.
20. Cosme-Blanco W, Shen MF, Lazar AJ, Pathak S, Lozano G, Multani AS, Chang S: Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 2007;8:497-503.
21. Mooi WJ, Peeper DS: Oncogene-induced cell senescence - halting on the road to cancer. N Engl J Med 2006;355:1037-1046.
22. Lazzerini DE, Attwooll C, Pasini D, Helin K: Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 2005;25:2660-2672.
23. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben Shlomo A, Kovacs K, Wawrowsky K, Melmed S: Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 2007;67:10564-10572.